Pain Management at End of Life: What, Why, How?
Pain is the symptom most feared by many patients with a terminal condition. According to the World Health Organization, pain management at the end of life is the right of the patient and the duty of the clinician. However, studies have shown that many patients suffer from untreated pain at the end of life. The inability to effectively treat pain often results from lack of clinician training in pain and symptom management, as well as fear of violating ethical, legal and professional standards in the administration of pain management at the end of life. This course will increase clinicians’ knowledge, skills, ability and comfort when caring for the dying patient in an interculturally diverse population.
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Nursing Students, Pharmacists, Medical Students, and other interested healthcare professionals.
- Define the legal and ethical differences between euthanasia, physician assisted-suicide, and natural death.
- Explain how the Principle of Double Effect provides ethical consensus in the standard treatment of pain at the end of life.
- Differentiate between the classifications of analgesics, their indications and side-effects and determine the most effective route of medication administration for end of life pain management.
- Adhere to professional and regulatory standards of care for appropriate pain management when caring for the patient at end of life.
Brenda Daniels, M.D.
Palliative Medicine Physician
Baptist Health South Florida
Rose Allen, DNP, MSM/HM, R.N., CHPN
Director, Bioethics Program
Baptist Health South Florida
Brenda Daniels, M.D., and Rose Allen, DNP, MSM/HM, R.N., CHPN, faculty for this educational activity, have no relevant financial relationships with ineligible companies* to disclose and have indicated that the presentations or discussions will not include off-label or unapproved product usage.
Ana Viamonte-Ros, M.D., conference director for this educational activity, has no relevant financial relationship with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit™
- 1.25 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.